"Tele-health tactics gained momentum and our clients made their pivot, like other industries, to fully remote operations. RxS, with our technology-forward approach, was prepared for the shift."
PRESIDENT – US INFECTIOUS DISEASES & VACCINES, JANSSEN PHARMACEUTICALS
"In vaccines, we are progressing late-stage programs of break-through vaccines against diseases where vaccines are not currently available, such as RSV and multidrug resistant bacterial infections, including ExPEC and Staphylococcus aureus."
"Ultimately, we aim to fine-tune this foundational technology that can be applied to innumerable challenges across a variety of industries, making biology become more like software and programming."
Africa has been attracting more diverse and innovative capital flows over recent years. The US, Europe, the Middle East, Japan, and even India are all crowding in, while China maintains its already well-established presence.